Organizations
Conferences
Info & Opinion
July 25, 2008
With eager investigators, South Africa is ripe for clinical trials. But regulatory delays are an issue.
Janice Sidorick was working in regulatory affairs for a pharmaceutical company that was starting up a cardiology trial. As Sidorick recalls, there were 250 sites with 500 patients in five countries. Most of the sites were in the U.S., Canada…
No articles available